Bruce N. Jacobs Kymera Therapeutics, Inc. (KYMR) insider trading activity
Bruce N. Jacobs is Chief Financial Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 227,409 shares of KYMR, which is worth approximately $14.8 Million. The most recent transaction as insider was on Jun 03, 2021, when has been sold 10,000 shares (Common Stock) at a price of $2.08 per share, resulting in proceeds of $20,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
227K
0%
3M change
34.92%
12M change
Total Value Held
$14.8 Million
Bruce N. Jacobs Transaction History
BNJ
Bruce N. Jacobs
Chief Financial Officer
Watertown, MA